Skip to main content

Table 2 Clinical changes after a switch from etanercept to infliximab

From: Effective use of TNF antagonists

Parameter Pre-infliximab (baseline) Post-infliximab (4 doses; week 14) Outcome
Mean tender joints (n) 17.1 7.3 57% reduction
Mean swollen joints (n) 11.2 3.8 66% reduction
ESR (mm/h) 33 26.5 20% reduction
Mean prednisone dosage (mg/day) 9.2 5.7 38% reduction
  1. ESR, erythrocyte sedimentation rate. Data from [17].